Global Tissue Scaffolds Market 2018-2022

  • ID: 4460847
  • Report
  • Region: Global
  • 131 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • MORE
About Tissue Scaffolds

Tissue scaffolds are cell growth supporting structures composed of natural or synthetic biocompatible materials that provide a favorable environment for cell proliferation and differentiation.

The analysts forecast the global tissue scaffolds market to grow at a CAGR of 12.14% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global tissue scaffolds market for 2018-2022. To calculate the market size, the report considers the revenue generated from the tissue scaffolds.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Tissue Scaffolds Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
Market drivers
  • Growing occurrence of chronic and acute wounds
  • For a full, detailed list, view the full report
Market challenges
  • Limitations of tissue scaffolds
  • For a full, detailed list, view the full report
Market trends
  • Increasing technological advances
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing
  • Market size and forecast
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Natural tissue scaffolds
  • Synthetic tissue scaffolds
  • Market opportunity by product
PART 08: MARKET SEGMENTATION BY APPLICATION
  • Segmentation by application
  • Comparison by application
  • Musculoskeletal
  • Dermatological
  • Cardiovascular
  • Others
PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Tissue scaffolds market in Americas
  • Tissue scaffolds market in EMEA
  • Tissue scaffolds market in APAC
  • Key leading countries
  • Market opportunity by region
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Growing M&A and strategic collaborations
  • Increasing technological advances
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • Other prominent vendors
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global regenerative medicine market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global tissue scaffolds market – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global natural tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global natural tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 22: Global synthetic tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global synthetic tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Tissue scaffold market by application – Market share 2017-2022 (%)
Exhibit 26: Customer landscape
Exhibit 27: Global tissue scaffolds market – Market share by region 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Tissue scaffolds market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Tissue scaffolds market in Americas – Year over year growth 2018-2022 (%)
Exhibit 31: Top two countries in Americas
Exhibit 32: Tissue scaffolds market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Tissue scaffolds market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 34: Top two countries in EMEA
Exhibit 35: Tissue scaffolds market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Tissue scaffolds market in APAC – Year over year growth 2018-2022 (%)
Exhibit 37: Top two countries in APAC
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity by geography
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Competitive structure analysis of global tissue scaffolds market 2017
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Bioventus: Overview
Exhibit 47: Bioventus: Business segments
Exhibit 48: Bioventus: Organizational developments
Exhibit 49: Bioventus: Geographic focus
Exhibit 50: Bioventus: Segment focus
Exhibit 51: Bioventus: Key offerings
Exhibit 52: Bioventus: Key customers
Exhibit 53: Integra LifeSciences: Overview
Exhibit 54: Integra LifeSciences: Business segments
Exhibit 55: Integra LifeSciences: Organizational developments
Exhibit 56: Integra LifeSciences: Geographic focus
Exhibit 57: Integra LifeSciences: Segment focus
Exhibit 58: Integra LifeSciences: Key offerings
Exhibit 59: Integra LifeSciences: Key customers
Exhibit 60: MiMedx Group: Overview
Exhibit 61: MiMedx Group: Business segments
Exhibit 62: MiMedx Group: Organizational developments
Exhibit 63: MiMedx Group: Geographic focus
Exhibit 64: MidMedx Group: Segment focus
Exhibit 65: MidMedx Group: Key offerings
Exhibit 66: MiMedx Group: Key customers
Exhibit 67: Organogenesis: Overview
Exhibit 68: Organogenesis: Business segments
Exhibit 69: Organogenesis: Organizational developments
Exhibit 70: Organogenesis: Geographic focus
Exhibit 71: Organogenesis: Segment focus
Exhibit 72: Organogenesis: Key offerings
Exhibit 73: Organogenesis: Key customers
Exhibit 74: RTI Surgical: Overview
Exhibit 75: RTI Surgical: Business segments
Exhibit 76: RTI Surgical: Organizational developments
Exhibit 77: RTI Surgical: Geographic focus
Exhibit 78: RTI Surgical: Segment focus
Exhibit 79: RTI Surgical: Key offerings
Exhibit 80: RTI Surgical: Key customers
Exhibit 81: Smith & Nephew: Overview
Exhibit 82: Smith & Nephew: Business segments
Exhibit 83: Smith & Nephew: Organizational developments
Exhibit 84: Smith & Nephew: Geographic focus
Exhibit 85: Smith & Nephew: Segment focus
Exhibit 86: Smith & Nephew: Key offerings
Exhibit 87: Smith & Nephew: Key customers
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • MORE
New Report Released: – Global Tissue Scaffolds Market 2018-2022

The author of the report recognizes the following companies as the key players in the global tissue scaffolds market: Bioventus, Integra Lifesciences, MiMedx Group, Organogenesis, RTI Surgical, and Smith & Nephew

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is increasing technological advances. There is an increasing trend of technological advances in the global tissue scaffolds market. The introduction of 3D printing or additive manufacturing is increasingly being adopted for manufacturing scaffolds as it allows the researcher to control the size, shape, pore size, geometry, and mechanical properties of the scaffold. Additionally, the integration of computer-assisted design and modern medical imaging allows customized designing of scaffolds. There is also an increasing focus on the development of scaffolds containing nanomaterials as they can mimic the architecture of the normal extracellular matrix containing both nanofibers and microfibers.”

According to the report, one of the major drivers for this market is Growing occurrence of chronic and acute wounds. There is an increasing global prevalence of acute wounds such as surgical and traumatic wounds (abrasion, puncture, laceration, and incision) and chronic wounds such as venous ulcers, diabetic ulcers, and pressure ulcers. It is estimated that more than 250 million acute wounds are treated every year. It is estimated that 40-60 million traumatic wounds occur every year globally. In 2016, the global prevalence of surgical wounds was more than 135,000.

Further, the report states that one of the major factors hindering the growth of this market is Limitations of tissue scaffolds. The use of scaffolds in tissue engineering is associated with various limitations such as material associated infection, mechanical failure of materials, and immunogenic reactions to implanted materials. In 2013, Medtronic recalled 16,994 units of its INFUSE due to possible elevated endotoxin levels resulting from a process deviation. Furthermore, scaffolds derived from biologic tissues are more challenging to produce and can have issues related to quality control and lot-to-lot variability. The use of tissue scaffolds in clinical applications is still in its relatively early stage.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll